Saraswathi Tenagi
Research Subjects
Research Interests
Saraswathi Tenagi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Anagha A. Tenagi
Bangalore Medical College, Bangalore, Karnataka, India
1 shared publicationAparna S Harbishettar
Dept. of General Medicine, Sanjay Gandhi Institute of Trauma and Orthopaedics, Bangalore, Karnataka, India
1 shared publication- Geetha Desai
National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
1 shared publication - Kesavan Muralidharan
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, Karnataka, India
1 shared publication - Krishna Prasad Muliyala
National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India
1 shared publication - Palanimuthu Thangaraju Sivakumar
Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India
1 shared publication
Latest Publications
- Open Access
- 18 June 2025
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 48 (2) , 117-126
Efficacy and Safety of Haloperidol in the Prevention and Management of Delirium in Medical Inpatients: An Umbrella Review of Systematic Reviews
Purpose of the review: Delirium occurs in up to 31% of general hospital patients in the medical, surgical, or critical care wards. Agitation is common during hyperactive delirium, which poses a risk to themselves, other patients, or staff. Evidence for using oral or parenteral haloperidol from randomized controlled trials and published systematic reviews shows divergent findings, ranging from good response to no difference compared to placebo, despite its popularity in routine clinical use. We decided to perform an umbrella review of systematic reviews on the efficacy and safety of haloperidol in delirium. Collection and Analysis of Data: This protocol was registered with PROSPERO CRD42024502020. We searched PubMed, Ovid MEDLINE, and PsychINFO for systematic reviews with meta-analyses published in English only over the previous 20 years. These were searched under title, abstract, and Medical Subject Headings (MeSH) terms as applicable. We used Assessing the Methodological Quality of Systematic Reviews 2 to assess the quality of the articles. Ten systematic reviews were finally selected for review that focused on either preventing or treating delirium. The summary of results did not find that haloperidol is effective in preventing or treating delirium, though all included reviews found it a safe drug to use. Heterogeneity from I 2 statistics varied from a moderate to a high degree and may be attributable to population, outcomes, and setting variations. Conclusions: The authors conclude that there is limited evidence for haloperidol in preventing or treating delirium. Future studies must not aim to assess the resolution of delirium; instead, they must modify outcome measures, to mainly behavioral and psychiatric symptoms such as agitation, hallucinations, and persecutory delusions in delirium.
- 18 June 2025
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 48 (2) , 117-126
Open AccessEfficacy and Safety of Haloperidol in the Prevention and Management of Delirium in Medical Inpatients: An Umbrella Review of Systematic Reviews
Purpose of the review: Delirium occurs in up to 31% of general hospital patients in the medical, surgical, or critical care wards. Agitation is common during hyperactive delirium, which poses a risk to themselves, other patients, or staff. Evidence for using oral or parenteral haloperidol from randomized controlled trials and published systematic reviews shows divergent findings, ranging from good response to no difference compared to placebo, despite its popularity in routine clinical use. We decided to perform an umbrella review of systematic reviews on the efficacy and safety of haloperidol in delirium. Collection and Analysis of Data: This protocol was registered with PROSPERO CRD42024502020. We searched PubMed, Ovid MEDLINE, and PsychINFO for systematic reviews with meta-analyses published in English only over the previous 20 years. These were searched under title, abstract, and Medical Subject Headings (MeSH) terms as applicable. We used Assessing the Methodological Quality of Systematic Reviews 2 to assess the quality of the articles. Ten systematic reviews were finally selected for review that focused on either preventing or treating delirium. The summary of results did not find that haloperidol is effective in preventing or treating delirium, though all included reviews found it a safe drug to use. Heterogeneity from I 2 statistics varied from a moderate to a high degree and may be attributable to population, outcomes, and setting variations. Conclusions: The authors conclude that there is limited evidence for haloperidol in preventing or treating delirium. Future studies must not aim to assess the resolution of delirium; instead, they must modify outcome measures, to mainly behavioral and psychiatric symptoms such as agitation, hallucinations, and persecutory delusions in delirium.
- Open Access
- 21 April 2025
- Published by SAGE Publications in Journal of Psychosexual Health
- Vol. 7 (2) , 195-196
Silver Divorce: Insights into Changing Marital Landscape
- 21 April 2025
- Published by SAGE Publications in Journal of Psychosexual Health
- Vol. 7 (2) , 195-196
Open AccessSilver Divorce: Insights into Changing Marital Landscape